NVDA trades against a final fair-value range of $203.19-$458.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $203, high $459, with mid-point at $336.
Trades below fair value with a meaningful cushion to the midpoint.
Fair value
$336
Margin of safety
+29.9%
Confidence
82/100
Moat
9.5/10
Educational analysis only — not financial advice. Always do your own due diligence.
$235.47Price
Low $203.19
Mid $336.1
High $458.69
NVDA trades against a final fair-value range of $203.19-$458.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
FY2026 revenue reached $215
FY2026 revenue reached $215.94B with gross margin 71.1% and operating margin about 60.4%, far above industry benchmarks near 59.0% gross and 35.3% operating.
Net cash and marketable investments
Net cash and marketable investments were about $62.56B at 2026-01-31, supporting reinvestment, supply commitments, and buybacks.
Bull thesis
Valuation is constructive because the $336.10 midpoint sits 42.74% above the $235.47 price.
If hyperscaler and enterprise buying slows materially after the explicit estimate window, the current thesis of sharp but orderly deceleration breaks, and the market can re-rate NVIDIA toward mature semiconductor frameworks.
FV impact
Could push value toward the low end of $203.19 or below current price.
Trigger
12-24 months
Margins revert faster than modeled
· Medium
The base case already fades operating margin from FY2026 peak conditions to 54%. If pricing, mix, or utilization weakens enough to drive a steeper reset, forward earnings would be overstated.
FV impact
Could compress value toward the conservative $160-$165 zone signaled by discounted earnings and owner earnings.
Beneish is elevated at -1.1321, Piotroski is only 4, and OCF to net income is 0.856. If cash conversion weakens further, investors may haircut reported earnings quality.
FV impact
Would justify lower multiples and narrower confidence in the upper half of the range.
Trigger
Next 2-4 filings
Early-warning signals to monitor
Metric
Current
Trigger threshold
Revenue growth missing the 72.11% and 31.24% near-term anchor path.
Monitor
Deterioration versus the report thesis
Operating margin falling well below the 54% normalized base case.
Monitor
Deterioration versus the report thesis
OCF to net income dropping below the current 0.856 level.
Monitor
Deterioration versus the report thesis
Inventory or receivables rising faster than revenue for multiple periods.
Monitor
Deterioration versus the report thesis
Market value consistently trading below the $203.19 low-end estimate after earnings.
Based on our latest analysis, NVDA looks meaningfully undervalued. The current price is $235 versus a composite fair-value midpoint of $336 (range $203–$459), which implies roughly 42.7% upside to the midpoint.
Our composite fair-value range for NVDA is $203–$459, with a midpoint of $336. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for NVDA's archetype.
Our current rating for NVDA is Strong Buy with a confidence score of 82/100. NVDA is rated Strong Buy at $235.47 versus the reconciled fair value midpoint of $336.10, implying +42.74% upside/downside. Confidence is separately disclosed at 82/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for NVDA are: AI demand digestion arrives early; Margins revert faster than modeled; Accounting quality warnings prove economically meaningful. The single biggest risk is The main risk is not balance-sheet weakness; it is paying too much for peak conditions that may fade faster than modeled.
Our current rating for NVDA is Strong Buy, issued with a confidence score of 82/100 and a moat score of 9.5/10. The rating reflects the composite fair-value range ($203–$459) versus the current price of $235.
NVDA is classified as a hyper-growth stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for NVDA.
